Cargando…
1458. Uncharted territories: applying “precision medicine” to understand the treacherous landscape of extensively and multidrug resistant (XDR and MDR) Pseudomonas aeruginosa in a patient with cystic fibrosis and lung transplantation
BACKGROUND: Pseudomonas aeruginosa is a persistent and difficult-to-treat pathogen in many patients, especially those with cystic fibrosis (CF). Herein, we describe our experience managing a young woman suffering from CF with XDR P. aeruginosa who underwent lung transplantation. We highlight the con...
Autores principales: | Rojas, Laura J, Yasmin, Mohamad, Benjamino, Jacquelynn, Marshall, Steven, DeRonde, Kailynn, Krishnan, Nikhil, Perez, Federico, Colin, Andrew, Cardenas, Monica, Martinez, Octavio, Perez-Cardona, Armando, Rhoads, Daniel, Jacobs, Michael, Scott, Jacob, Adams, Mark D, Abbo, Lilian M, Bonomo, Robert A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776507/ http://dx.doi.org/10.1093/ofid/ofaa439.1639 |
Ejemplares similares
-
635. Genomic Evolution and Progression of Antimicrobial Resistance in a Series of Extensively Drug-Resistant Pseudomonas aeruginosa (XDR-Pa) Isolates from a Cystic Fibrosis Lung Transplant Recipient
por: Yasmin, Mohamad, et al.
Publicado: (2019) -
1611. Evaluating Clinical Outcomes and Efficacy of Daptomycin in Combination with a Beta-Lactam for the Treatment of Vancomycin-Resistant Enterococcus (VRE) Bacteremia
por: Irusta, Nerea, et al.
Publicado: (2020) -
110. Impact of Diagnostic and Antimicrobial Stewardship on Time-to-Appropriate Therapy and Clinical Outcomes in Multi-Drug Resistant Pseudomonas Infections
por: McCrink, Katie A, et al.
Publicado: (2020) -
2395. Mechanism-Based-Susceptibility Testing (MBST) Using Disc Diffusion Assays (DDA) to Guide Treatment of Multidrug- and Extensively Drug-Resistant Pseudomonas aeruginosa (MDR-XDR-Pa) in a Cystic Fibrosis (CF) Lung Transplant Recipient; Are We Ready for Combination Therapy vs. MDR-XDR-Pa?
por: Abbo, Lilian M, et al.
Publicado: (2018) -
Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing
por: Rojas, Laura J., et al.
Publicado: (2022)